{"url_path":"/sec/ctor/10-q/2026/item-2","section_key":"item-2","section_title":"Item 2 Unregistered Sales of Equity Securities","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-15","source_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-057841-index.html","accession_number":"0001213900-26-057841","cik":"0001851484","ticker":"CTOR","issuer_name":"CITIUS ONCOLOGY, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1851484/0001213900-26-057841-index.html","primary_entity_key":"0001851484","primary_entity_name":"CITIUS ONCOLOGY, INC."},"word_count":30,"has_tables":true,"body_markdown":"**Item 2. Unregistered Sales of Equity Securities\nand Use of Proceeds.**\n\n \n\nDuring the quarter ended March 31, 2026, we did\nnot issue or sell any unregistered securities not previously disclosed."}